Results 131 to 140 of about 760,147 (214)

Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022. [PDF]

BMC Med
Zhang X, Peck CC, Wang Y, Szucs TD, Sun W, Bai X, Chen S, Wang F, Wu Y.   +8 more
europepmc   +1 more source

Isotretinoin and Suicide: Data Mining of the United States Food and Drug Administration Adverse Event Reporting System Database. [PDF]

Cureus
Ganjikunta RK, Naik RB, Vallepalli C, M J.   +3 more
europepmc   +1 more source

The First 10 Years: Reflecting on Opportunities and Challenges of the Tobacco Products Scientific Advisory Committee of the United States Food and Drug Administration. [PDF]

J Leg Med, 2020
Fagan P, Eissenberg T, Jones DM, Cohen JE, Nez Henderson P, Clanton MS.   +5 more
europepmc   +1 more source

Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system. [PDF]

Sci Rep
Kamath A.
europepmc   +1 more source

Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections. [PDF]

J Am Acad Dermatol, 2020
Wang Y, Lipner SR.
europepmc   +1 more source

The Role of Patient- and Drug-Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System. [PDF]

J Cosmet Dermatol
Gupta AK, Bamimore MA, Haber R, Williams G, Piguet V, Talukder M.   +5 more
europepmc   +1 more source

Drug-associated congenital anomalies of the external ear identified in the United States food and drug administration adverse event reporting system database. [PDF]

Sci Rep
Li X, Hao J, Li D, Zhang R.
europepmc   +1 more source

Disproportionality analysis of drug-induced dry mouth using data from the United States food and drug administration adverse event reporting system database. [PDF]

Heliyon
Xu D, Zhu H, Wu M.
europepmc   +1 more source

Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study. [PDF]

Front Pharmacol
Wu J, Wu J, Tang B, Wang X, Wei F, Zhang Y, Li L, Li H, Wang B, Wu W, Hong X.   +10 more
europepmc   +1 more source

Assessment of safety profile of secukinumab in real-world scenario using United States food and drug administration adverse event reporting system database. [PDF]

Sci Rep
Eshwar V, Kamath A.
europepmc   +1 more source